We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 12, 2021

Two-Year Survival With Nivolumab in Previously Treated Advanced Non–Small Cell Lung Cancer

Lung Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

Lung Cancer
Two-Year Survival With Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: A Real-World Pooled Analysis of Patients From France, Germany, and Canada
Lung Cancer 2021 Apr 30;[EPub Ahead of Print], D Debieuvre, RA Juergens, B Asselain, et al

Further Reading